A Randomized, Single-blind, Active-controlled, Mono-center Phase II Study to Compare the Safety and Neutralizing Activity of Simulated Rabies Post-exposure Prophylaxis With CL184 in Combination With Purified Vero Cell Rabies Vaccine vs. Human Rabies Immune Globulin or Placebo in Combination With Purified Vero Cell Rabies Vaccine vs. CL184 or Placebo in Combination With Human Diploid Cell Rabies Vaccine in Healthy Adult Subjects.
Phase of Trial: Phase II
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Foravirumab; Rabies immune globulin; Rabies vaccine
- Indications Rabies
- Focus Adverse reactions
- 25 Jun 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 15 Feb 2012 New source identified and integrated (Clinical Trials Registry - India).
- 03 Feb 2012 Actual initiation date (Dec 2011) added as reported by ClinicalTrials.gov.